Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
about
Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@en
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@nl
type
label
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@en
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@nl
prefLabel
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@en
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@nl
P2093
P2860
P1476
Anticoagulant Therapy in Atria ...... 2DS2-VASc and HAS-BLED Scores.
@en
P2093
Latif Gachkar
Marzieh Balaghi-Inalou
Sasan Andalib
P2860
P2888
P356
10.1007/S40292-017-0237-9
P577
2017-10-26T00:00:00Z